Summary of Purpose
Background: The plant-derived omega-3 fatty acid alpha-linolenic acid (ALA, 18:3-n-3) may reduce the risk of atherosclerotic cardiovascular disease, including incident myocardial infarction, ischemic stroke and peripheral artery disease. However, the results of previous studies have been inconsistent. Objectives: To investigate the associations between dietary intake of ALA, adipose tissue content of ALA,...Read More →
The following dates are available for this trial. Trial information last updated on 19 August 2017.
|24 Nov 1993||19 Aug 2017||10 Jul 2013||10 Jul 2013||1 Aug 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|